- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
回复 wangxinghao 的帖子
替诺福韦 服药可以母乳
Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence
Stephan Ehrhardt1,*, Chan Xie2,*, Nan Guo1, Kenrad Nelson1,3,4, and Chloe L. Thio3,5
+
Author Affiliations
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America
2Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China
3Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States of America
4Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America
For correspondence: Chloe L. Thio, MD, Professor of Medicine, Johns Hopkins University, 855 N Wolfe St, Suite 520, Baltimore, MD 21205, Ph: 410-614-6088, Email: [email protected]
↵* These authors contributed equally to this work.
Abstract
Lamivudine and tenofovir disoproxil fumarate (TDF) are both active against hepatitis B virus (HBV). Due to its potency, high genetic barrier to resistance, and safety during pregnancy, TDF may be useful to prevent HBV transmission from mother-to-child, which is the leading cause of transmission globally. Despite the safety record of lamivudine and TDF in pregnancy, the labels for both of these drugs recommend against their use during breastfeeding. In this review, we discuss the data regarding lamivudine and TDF use during pregnancy and breastfeeding and find that the exposure to the drug is lower from breastfeeding than from in utero exposure. Thus, the data do not support the contraindication to their use during breastfeeding.
同时服用拉米夫定或富马酸替诺福韦酯母乳喂养:证据的审查
斯蒂芬Ehrhardt1,*,陈Xie2,*,南果1,Kenrad Nelson1,3,4,和Chloe L. Thio3,5
+
作者机构
流行病学教研室的,公共卫生,马里兰州巴尔的摩,美国约翰霍普金斯大学彭博学院
传染病教研室,第三附属医院孙中山大学,广州市,广东省,中国
3Division传染病,医学,约翰霍普金斯大学,巴尔的摩,MD,美国系
国际卫生,公共卫生约翰霍普金斯大学彭博学院,马里兰州巴尔的摩,美国的4Department
分子微生物学和免疫学,公共卫生约翰霍普金斯大学彭博学院,马里兰州巴尔的摩,美国的5Department
对于信件:克洛伊L.硫代,医学博士,医学教授,美国约翰霍普金斯大学,855Ñ沃尔夫街,520套房,马里兰州巴尔的摩21205,电话:410-614-6088,电邮:[email protected]
↵*这些作者贡献同样对这项工作。
抽象
拉米夫定和富马酸替诺福韦酯(TDF)都是积极的抗乙型肝炎病毒(HBV)。由于其在怀孕期间效力,高耐药基因屏障,安全,TDF可能是有用的,以防止乙肝病毒母婴传播给孩子,这是全球性传播的主要原因。尽管拉米夫定和TDF在怀孕的安全记录,对于这两种药物的标签建议对哺乳期间它们的使用。在这次审查中,我们讨论有关拉米夫定和TDF利用这些数据在怀孕和哺乳期间,如果发现暴露于药物较低母乳喂养不是从子宫内暴露。因此,该数据不哺乳期间支持禁忌其使用。 |
|